G3P-01 in Volunteers With Elevated Galectin-3

Inclusion Criteria: * Invited through cohort study. * Plasma galectin-3 level of 16 ng/mL or higher * Male and female subjects ≥45 and ≤75 years of age * Females will be non-pregnant, non-lactating, and have no intent to become pregnant during the study period. * Able to participate in the study in the opinion of the Investigator. * Has the ability to understand the requirements of the study and is willing to comply with all study procedures. * An Independent Ethics Committee or in Dutch Medisch- Ethische Toetsingscommissie (METC) -approved informed consent is signed and dated prior to any study-related activities. Exclusion Criteria: * Existing clinically significant concurrent medical condition which in the opinion of the Investigator may interfere with the study. * Clinically significant abnormal laboratory test values, as determined by the Investigator, at Screening. * Participation in a clinical trial of an investigational drug within 30 days prior to Screening, or is currently participating in another trial of an investigational drug, supplement or device.